Status:
COMPLETED
Lung Bioavailability With Continuous or Discontinuous Nebulization
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Healthy Subjects
Eligibility:
MALE
18-50 years
Phase:
NA
Brief Summary
To compare the continuous and sicontinuous delivery of drug with AKITA.
Eligibility Criteria
Inclusion
- no lung disease
- no allergy
Exclusion
- smoker
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01913184
Start Date
April 1 2012
End Date
June 1 2012
Last Update
July 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques universitaires Saint-Luc
Brussels, Belgium, 1200